2162 — Keymed Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapSucker Stock

Annual balance sheet for Keymed Biosciences, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	499	354	3,525	3,175	2,719
Net Total Accounts Receivable
Net Total Receivables	1.23	1.23	13.6	7.44	27.1
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	518	381	3,582	3,310	2,940
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	129	126	306	596	894
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	659	530	3,934	3,932	3,883
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	71.6	80.2	112	380	314
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	935	1,624	283	592	897
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	-276	-1,095	3,651	3,340	2,986
Total Liabilities & Shareholders' Equity	659	530	3,934	3,932	3,883
Total Common Shares Outstanding